Astellas Pharma | 4503 - Gross Profit On Sales

Stock Price
1,695.00
Daily Change
-29.00 -1.68%
Monthly
2.79%
Yearly
-5.36%
Q3 Forecast
1,683.14

Astellas Pharma reported JPY410.96B in Gross Profit on Sales for its fiscal quarter ending in June of 2025.



Financials
Stock Price JPY
Assets JPY 3335.83B
Cash and Equivalent JPY 188.37B
Cost of Sales JPY 94.83B
Current Assets JPY 1293.33B
Current Liabilities JPY 1107.94B
Debt JPY 831.43B
Dividend Yield 5.22
EBIT JPY 92.54B
EBITDA JPY 140.35B
Employees 14.75K
EPS Earnings Per Share JPY 38.22
Equity Capital and Reserves JPY 1481.79B
Gross Profit on Sales JPY 410.97B
Interest Expense on Debt JPY 3.91B
Interest Income JPY 4.12B
Loan Capital JPY 558.08B
Market Capitalization JPY 3086.15B
Net Income JPY 68.42B
Operating Expenses JPY 413.25B
Operating Profit JPY 92.54B
Ordinary Share Capital JPY 1.79B
PE Price to Earnings JPY 9.35
Pre-Tax Profit JPY 90.42B
Sales Revenues JPY 505.79B
Selling and Administration Expenses JPY 197B
Stock JPY 297.26B
Trade Creditors JPY 165.89B
Trade Debtors JPY 699.51B

Gross Profit On Sales Change Date
Astellas Pharma JPY 410.96B 28.53B Jun/2025
Chugai Pharma JPY 201.94B 1.3B Jun/2025
Daiichi Sankyo JPY 382.25B 42.1B Jun/2025
Eisai JPY 160.05B 12.42B Jun/2025
Kyowa Hakko Kirin JPY 88.65B 8.52B Jun/2025
M3 JPY 44.58B 5.22B Jun/2025
Otsuka Holdings JPY 429.15B 2.96B Jun/2025
Shionogi JPY 87.46B 587M Jun/2025
Sumitomo Dainippon JPY 65.98B 5.02B Mar/2025
Takeda JPY 722.01B 50.69B Jun/2025
Terumo JPY 145.47B 6.94B Jun/2025